טוען...
Inhibiting TrxR suppresses liver cancer by inducing apoptosis and eliciting potent antitumor immunity
Liver cancer is one of the most common malignant tumors worldwide. Thioredoxin reductase (TrxR) is highly expressed in liver cancer cells. The present study aimed to investigate the effect of inhibiting TrxR on liver cancer and to better understand the underlying molecular and immunological mechanis...
שמור ב:
| הוצא לאור ב: | Oncol Rep |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
D.A. Spandidos
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6196602/ https://ncbi.nlm.nih.gov/pubmed/30272318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2018.6740 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|